Market research

The global surgical simulation market is estimated to grow at a CAGR of XX .XX % to reach a market size of US$XX .XX billion in 2023 from US$XX .XX billion in 2017. Surgical simulation is a technology that was developed to stimulate the surgical process without using any subject such as the human body or animal. The surgical simulation market is projected to witness a healthy   grow th in the next five years on account of the growing prevalence of diseases, which is resulting in an increase in demand for doctors. Simultaneously, t here is also an increase in demand for minimally invasive treatment  solutions  owing to the reduced blood loss, a short stay at the hospital, less pain and reduced re covery period, thus requiring specialized training for the medical professionals. Additionally, growing disposable i ncome in the emerging markets, g reater healthcare spending by the government and increasing focus on the safety of patients are acting as supplements wh...

The global  blood transfusion diagnostics market is expected to reach $XX.XX billion by 2023 from US$XX.XX billion in 2017, at a CAGR of 5.48%. Blood transfusion diagnostics include the instruments that are used to screen and conduct tests before transfusion of blood and blood products from donor to recipient. Increasing number of infectious diseases coupled with growing demand for blood and blood component transfusions owing to a large patient population base suffering from chronic diseases such as aplastic anemia, thalassemia, and leukemia are some of the major drivers attracting numerous market players to invest in and develop blood transfusion diagnostics technologies. Global Blood Transfusion Diagnostics Market Forecast, 2017-2023, US$ Billion Global Blood Transfusion Diagnostics Market by Technology: By  technology, the blood transfusion diagnostics market is segmented as ELISA, Western Blottin...

T he global CRISPR market was valued at US$551.242 million in 2017 and is expected to grow at a CAGR of 33.26% to reach a total market size of US$3,086.697 million in 2023. CRISPR is one of the most popular tools for genome editing or engineering. This method utilizes a modified bacterial protein and RNA to facilitate DNA sequences alteration and gene function modification. Unparalleled control over genes offered by this tool has been increasing its popularity among researchers. Ongoing research in rare and orphan diseases and huge investments being pumped by market players into them are boosting the growth of the market. However, ethical concerns associated with genome editing have been restraining the market growth to some extent. Global CRISPR market by Geography : T he global CRISPR  market  was valued at US$ 551.242 million in 2017 and is expected to grow at a CAGR of 33.26% to reach a total market size of US$ 3 , 086.697 million in 2023. CRISPR is...